Teveten HCT

Special information if you are pregnant or breastfeeding

When used in the second or third trimester of pregnancy, Teveten HCT can cause injury or even death to the unborn child. Alert your doctor as soon as you learn you are pregnant. Teveten HCT should be discontinued as soon as possible.

This drug is not recommended if you plan to breastfeed.

Recommended dosage for Teveten HCT

ADULTS

Teveten HCT comes in two strengths: 600/12.5 and 600/25 (600 milligrams of eprosartan and either 12.5 milligrams or 25 milligrams of hydrochlorothiazide). The usual starting dose is one 600/12.5 tablet per day. If your blood pressure remains too high, the doctor may increase the dose to one 600/25 tablet per day.

Overdosage

Little is known about overdosage with Teveten HCT. The most likely symptoms would be those of chemical imbalance triggered when the hydrochlorothiazide in the product flushes too much water from the system. These symptoms include thirst, diminished urination, weakness, drowsiness, restlessness, confusion, seizures, muscle pain, nausea, vomiting, and rapid heartbeat. If you suspect an overdose, seek medical attention immediately.